Facultad de Medicina
Facultad
Vicente
Soriano Vázquez
Publicaciones en las que colabora con Vicente Soriano Vázquez (34)
2016
-
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
Journal of Translational Medicine, Vol. 14, Núm. 1
-
Short communication: CXCL12 rs1029153 polymorphism is associated with the sustained virological response in HIV/Hepatitis C virus-coinfected patients on Hepatitis C Virus therapy
AIDS Research and Human Retroviruses, Vol. 32, Núm. 3, pp. 226-231
2014
-
European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients
HIV Medicine, Vol. 15, Núm. 7, pp. 425-430
-
PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy
Journal of Acquired Immune Deficiency Syndromes, Vol. 67, Núm. 2, pp. 113-119
2013
-
Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients
AIDS, Vol. 27, Núm. 2, pp. 163-173
-
HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy
AIDS, Vol. 27, Núm. 8, pp. 1231-1238
-
IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients
Journal of Viral Hepatitis, Vol. 20, Núm. 5, pp. 358-366
2012
-
Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up
AIDS, Vol. 26, Núm. 11, pp. 1387-1392
2001
-
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
American Journal of Gastroenterology, Vol. 96, Núm. 1, pp. 179-183
-
Intensification of antiretroviral therapy
AIDS Research and Human Retroviruses, Vol. 17, Núm. 6, pp. 499-506
-
Management of hepatitis C in HIV-infected persons
Antiviral Research, Vol. 52, Núm. 2, pp. 189-198
-
Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens [3]
Journal of Acquired Immune Deficiency Syndromes
2000
-
Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
AIDS, Vol. 14, Núm. 4, pp. 383-386
-
Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients
Journal of Human Virology, Vol. 3, Núm. 6, pp. 335-340
-
Intensificación del tratamiento antirretrovírico
Revista Clinica Espanola, Vol. 200, Núm. 2, pp. 84-87
-
Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients
AIDS, Vol. 14, Núm. 15, pp. 2409-2410
-
Second Spanish Consensus on the Use of Drug Resistance Testing in Clinical Practice (Madrid, March 2000)
AIDS Reviews
-
Terapia antirretrovírica de rescate
Revista Clinica Espanola, Vol. 200, Núm. 2, pp. 88-94
1999
-
Diabetes mellitus associated with protease inhibitor use
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 9, pp. 675-677
-
El virus de la hepatitis C: tras los pasos del virus de la inmunodeficiencia humana.
Revista clínica española